Jiung-Liang Liu

Title: Jiung-Liang Liu: Innovator in Antibody Formulations

Introduction

Jiung-Liang Liu is a notable inventor based in Chiayi, Taiwan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody formulations. His work focuses on creating effective therapeutic solutions for various medical conditions.

Latest Patents

Jiung-Liang Liu holds a patent for an "Antibody-containing aqueous formulation and use thereof." This patent describes an innovative formulation that includes a therapeutically effective amount of an anti-interleukin-6 receptor antibody, a protein stabilizer, a surfactant, and a buffer. The formulation is designed to maintain a pH ranging from 4.5 to 6.5, utilizing either an acetate buffer or a histidine buffer. This advancement has the potential to enhance the efficacy of treatments involving interleukin-6 receptor antibodies.

Career Highlights

Jiung-Liang Liu is currently associated with Richter Gedeon Nyrt., a prominent pharmaceutical company. His role involves research and development in the field of antibody therapies, where he applies his expertise to create innovative solutions for healthcare challenges. His dedication to advancing medical science is evident in his patent and ongoing research efforts.

Collaborations

Throughout his career, Jiung-Liang Liu has collaborated with esteemed colleagues, including Wen-Cheng Chang and Jheng-Gang Yang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of effective therapeutic solutions.

Conclusion

Jiung-Liang Liu's contributions to the field of antibody formulations exemplify the impact of innovative thinking in biopharmaceuticals. His patent and collaborative efforts highlight the importance of research in developing effective treatments for patients.